Table 2.
Group means and mean differences (95% CI) for VAS pain and Vancouver Scar Scale at 48-hour follow-up
| Desfecho | Controlen = 52 | Experimentaln = 52 | DM (95%CI)Experimental vs. Control |
|---|---|---|---|
| Reavaluation − 48 h(Mean ± EPE) | Reavaluation − 48 h(Mean ± EPE) | Reavaluation − 48 h | |
| EVA (0–10) | 5.5 ± 0,3 | 4.1 ± 0.3 | -1.4 (-2.3; -0.5) |
| Vancouver (0–13) | 5,07 ± 0,32 | 1,76 ± 0,30 | 3,31 (3.19; 3.43) |
| Thickness (0–3) | 1,39 ± 0,13 | 1,11 ± 0,12 | -0,28 (-0.63; 0.07) |
| Vascularization (0–3) | 1,41 ± 0,07 | 0,41 ± 0,08 | 1.0 (1.00; 1.03) |
| Pigmentation (0–2) | 0,12 ± 0,06 | 0,17 ± 0,06 | 0,08 (-0,11; 0,27) |
| Flexibility (0–5) | 1,18 ± 0,11 | 0,07 ± 0,12 | 1.11 (1.07; 1.15) |
VAS− Visual Analogue Scale (0 – 10). Low values indicate reduced pain perception. Vancouver Scar Scale (0 – 13). Low values indicate better quality of healing. MD− Estimated mean difference; EPE− Standard error of estimate